Market Signal Briefing

Important DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted as, a recommendation or advice to take any action, including making any investment or purchasing any product. Before making any financial decision, you should conduct your own due diligence, exercise your own discretion, and consult with competent advisors. The content on this website is not personally directed to you, and we do not take into account your individual financial situation or needs. The information contained on this website is not necessarily provided in real time, nor is it guaranteed to be accurate. Prices displayed may be provided by market makers and not by exchanges. Any trading or other financial decision you make is entirely your own responsibility, and you must not rely solely on any information provided through the website. FXEmpire does not provide any warranty regarding the accuracy, completeness, or reliability of any information contained on the website and shall bear no responsibility for any trading losses you may incur as a result of using such information. The website may include advertisements and other promotional content. FXEmpire may receive compensation from third parties in connection with such content. FXEmpire does not endorse, recommend, or assume responsibility for the use of any third-party services or websites. Empire Media Network LTD., its employees, officers, subsidiaries, and affiliates shall not be liable for any loss or damage resulting from your use of the website or reliance on the information provided herein.Risk DisclaimersThis website contains information about cryptocurrencies, contracts for difference (CFDs), and other financial instruments, as well as about brokers, exchanges, and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and involve a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money. FX Empire encourages you to conduct your own research before making any investment decision and to avoid investing in any financial instrument unless you fully understand how it works and the risks involved.

In brief
Trump Media and Crypto.com are working with Yorkville Acquisition Corp. to create a publicly traded Cronos treasury firm.
The deal closing is expected in Q1 2026, at which point the firm will be renamed Trump Media Group CRO Strategy, Inc.
CRO, its treasury asset, has dropped more than 8% in the last day and is now down 90% from its 2021 all-time high.
Trump Media and Technology Group and Crypto.com are one step closer to a business combination that will mark them as affiliates in a publicly traded Cronos (CRO) treasury—one that has ambitions of holding over $6 billion worth of the cryptocurrency.

Yorkville Acquisition Corp., now trading on the Nasdaq as MCGA, confidentially filed an S-4 with the SEC to establish Trump Media Group CRO Strategy, Inc. via a business combination, it announced on Monday. 

The firm also appointed two key executives, Steve Gutterman as CEO and Sim Salzman as CFO, who are expected to take their roles in Q1 with the anticipated business combination closing. The business combination is subject to customary closing costs.

“MCGA is uniquely positioned to scale and create shareholder value. No one else has the partners or the positioning that we do,” said Gutterman in a statement. “Sim and I could not be more excited to lead MCGA and to work with the teams at Yorkville, Crypto.com, and Trump Media to Make CRO Great Again.”

First announced in August, the treasury focuses on the Crypto.com platform’s native token, CRO, and is expected to initially open with 6.3 billion CRO, $200 million in cash, $220 million in warrants, and an additional $5 billion equity line of credit (ELOC).

At the time of the announcement, the treasury’s anticipated CRO holdings were valued around $1 billion, but the present day value of 6.3 billion CRO tokens is now around $636 million—a loss of around 36% as CRO has slid more than 30% in the last month of trading.

A representative for the firm did not immediately respond to Decrypt's request for comment and clarification on the current treasury holdings.

Note that with CRO's recent price decline, the asset's market cap sits at $3.7 billion, though the fully diluted valuation including locked tokens tops $9.7 billion. But the treasury plan is likely built around the expectation that CRO's price will rise over time, and perhaps that its own purchases would help fuel that growth.

The treasury will also establish and operate a Cronos validator node, delegating its CRO assets to the validator with expectations of earning around 6% APY in staking rewards, according to an investor presentation.

“The founding partners believe CRO offers a unique opportunity,” the firm said in a written statement from September. “It represents the backbone of a growing blockchain ecosystem (Cronos). CRO enables both utility (transactions, fees, governance) and yield generation (staking rewards).”

In August, Trump Media, which bought around $2 billion worth of Bitcoin and related equities in July, said it would buy $105 million of CRO and use the token in a rewards program across its Truth Social and Truth+ platforms. 

Shares of Trump Media (DJT) are down around 6% on Monday, recently changing hands at $10.88. DJT has now fallen 49% in the last six months. 

Shares of MCGA are flat on the day, but the firm’s treasury asset, CRO, has fallen 8.3% in the last 24 hours and recently traded at nearly $0.10—around 90% off its 2021 all-time high of $0.96.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

Journalist

Posted: December 1, 2025

Ethereum [ETH] is still the base layer that keeps Web3 running, but the activity it once hosted is now happening somewhere else.

New data shows Layer-2 networks are handling most of the ecosystem’s transactions, even as Ethereum continues to power the system underneath. It keeps the “digital oil” idea alive, just with the combustion moving off-chain.

At the same time, Ethereum’s own numbers are cooling.

L2s now control most of Ethereum’s transaction flow

Source: Dune Analytics

The pie chart shows how Polygon, Arbitrum, and Optimism dominate total transactions, leaving only a small share for smaller rollups like Linea, Scroll, and zkSync.

This isn’t a one-off. Daily transaction data shows Polygon and Arbitrum consistently processing between 2-4 million transactions a day, while Optimism adds more activity.

Together, these L2s handle far more traffic than Ethereum’s mainnet, so users have clearly moved to cheaper, faster layers.

What does that mean for Ethereum’s “digital oil” narrative?
The metaphor still resonates, especially with EIP-1559’s fee burn and the long-held idea that Ethereum’s utility should support its value. And yet, ETH supply has turned inflationary again, even as L2 usage grows.

Source: Arkham

Critics argue this is the result of revenue moving off-chain, with sequencer fees and MEV captured by rollups instead of returning to Ethereum itself.

Supporters counter that Ethereum’s role is evolving into core infrastructure, making it less a commodity and more the digital land everything is built on.

A slower L1 doesn’t mean a weaker ETH
DeFiLlama data shows TVL easing to around $66 billion, continuing the downtrend through late 2025. Activity is clearly migrating to L2s. Yet derivatives traders aren’t treating ETH like a fading asset.

Source: DeFiLlama

AMBCrypto previously reported that CryptoQuant CEO Ki Young Ju flagged Ethereum as significantly undervalued, noting that 10 out of 12 valuation models show ETH trading far below its fair worth.

At the time, the Composite Fair Value estimated ETH near $4.8k, implying the asset was still around 59% undervalued despite macro weakness.

Aggregated Open Interest remains elevated above $15 billion, and Funding Rates stay consistently positive. The market still prices ETH as core infrastructure rather than a trade people are exiting.

Source: Coinalyze

Even as usage thins on the base layer, the believers haven’t gone anywhere.

Final Thoughts

Ethereum’s value case stays intact as L2 adoption surges and models still price ETH far above current levels.
Despite weaker L1 metrics, there is confidence.

Bitcoin has fallen well below its October peak near $125,000 and has traded around $86,000, as extreme fear, long liquidations and ETF outflows have pushed traders toward defensive positioning, leaving only selective gains in MYX Finance and JUST while a broader altcoin season has stayed distant.

TL;DR:

Michael Saylor hinted at a shift in capital strategy after the market net asset value (mNAV) fell below 1.0x.
Strategy Inc.’s corporate guidance indicates that an MSTR stock buyback is prioritized under this threshold.
MSTR shares are testing the $170 support, with analysts projecting an initial rebound target of $235.

Michael Saylor used his X account to hint at adding “green dots” to Strategy Inc.’s charts, refocusing market attention on the market net asset value (mNAV) zone below 1.0x, which is favorable for stock repurchases. Simultaneously, technical analysts are mapping a potential recovery path for MSTR shares from support near $170 toward an initial target of $235.

Saylor suggested a potential shift in Strategy’s capital playbook after the company’s mNAV fell below 1.0x this week. Saylor asked on X: “What if we start adding green dots?”, accompanying charts of the firm’s Bitcoin portfolio and its capital guidance.

Strategy’s corporate guidance clearly states that when the mNAV falls “Below 1.0x mNAV,” the company will “consider issuing credit to repurchase MSTR.” This threshold contrasts with higher mNAV bands, where Strategy plans to issue stock to acquire more Bitcoin. The firm’s Bitcoin portfolio chart, dated November 30, 2025, shows holdings of 649,870 BTC.

Minutes after the executive’s tweet, X user Crypto Kid noted that Strategy’s mNAV had dropped below 1.0x just two days earlier, suggesting that the move should point to an MSTR stock buyback rather than another Bitcoin purchase. It is now notable that Saylor used the “green dot” phrase not only concerning Bitcoin accumulation but also regarding potential stock repurchases when the company’s equity trades below its stated valuation.

Technical Analysis: MSTR Fights to Reclaim Key Levels
Strategy Inc.’s (MSTR) shares are testing initial recovery levels after a steep sell-off. Currently, the price is moving just above the $170 support, while working to break a resistance band between $177 and $190.

Han Akamatsu wrote on X that reclaiming $180 would mark “the first positive step” toward a new bullish trend. He noted that the 1-day Hull Moving Average (HMA) is currently capping the price in the $177 to $190 zone.

According to momentum indicators, there is still stress, but they hint at stabilization. The daily Relative Strength Index (RSI) remains in oversold territory but has started to curl higher, suggesting that selling pressure may be easing.

In summary, if buyers defend the $170 floor and avoid a sharp rejection from the $190 area, Akamatsu sees an initial upside target around $235, a move that would be strongly propelled by the confirmation of the MSTR stock buyback.

Analysts cite historical patterns, macro trends, and technical signals as reasons Shiba Inu may be nearing a bottom and preparing for a major rebound.

Newton Gitonga2 min read

1 December 2025, 05:07 PM

Analysts maintain confidence in a Shiba Inu recovery despite the token’s steep decline over recent months. Their stance rests on historical patterns that suggest the current downturn may mirror earlier stages of major rallies. The broader market environment also shows early signs of improving risk appetite. As a result, analysts argue that patient holders could benefit if conditions align in the coming months.

Historical Patterns Strengthen Recovery ExpectationsDigital Asset Research stated in a recent X post that Shiba Inu may be nearing its bottom after a prolonged decline. The firm pointed to SHIB’s 20% drop over the past 30 days and its 62% slide since January as part of a familiar cycle seen five years ago. The analysis recalled that SHIB peaked in August 2020 before losing 99% of its value over 120 days, reaching a low in December that year. It added that the token then delivered an explosive rally in 2021, hitting $0.00008854.

The commentary noted that meme coins have followed a similar trajectory this cycle. Several of them topped in August before recording sharp corrections through the following months. Because of this pattern, the analyst argued that it would be unwise to “grave dance” on the asset while market conditions repeat a 60-month rhythm. He emphasized that such moments often create high-reward opportunities for disciplined investors willing to hold through volatility.

Market Cycles and Technical Signals Support a ReboundShiba Inu approaches the end of a full year of bearish activity across meme coins. The analyst explained that SHIB enjoyed a strong market run in December 2024 and early January before its extended correction took hold. He predicted that the downtrend could fade soon as the 360-degree cycle nears completion. The analysis added that this setup resembles the conditions that preceded the 2021 surge.

Technical factors may also help strengthen recovery prospects. The analyst cited Bitcoin dominance reaching multi-year highs, which often precedes rotation into altcoins. He also noted that Shiba Inu trades near oversold territory and that Ethereum may form a bottom this month. These factors, he argued, could combine to spark bullish momentum into early 2026.

Digital Asset Research expects “some huge winners” between February and March 2026 if these signals align. The projection aligns with a bold outlook from Meme Whale, who suggested that Shiba Inu might rally to between $0.001 and $0.01 by April 2026. His range represents potential gains of 12,330% to 124,200% from SHIB’s current price of $0.000007942.

SHIB price chart, Source: CoinMarketCap

ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!

Newton Gitonga

Newton Gitonga covers cryptocurrencies, blockchain, and digital finance. He specializes in breaking down complex trends with clear, data-driven reporting. His work focuses on market analysis, technical insights, and the evolving role of altcoins in shaping global markets.

Read more about

Latest Shiba Inu News Today (SHIB)

Skyward Specialty Insurance (SKWD - Free Report) closed the last trading session at $48.96, gaining 7.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $61.4 indicates a 25.4% upside potential.

The mean estimate comprises 10 short-term price targets with a standard deviation of $8.06. While the lowest estimate of $49.00 indicates a 0.1% increase from the current price level, the most optimistic analyst expects the stock to surge 53.2% to reach $75.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

But, for SKWD, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You Should Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.

Why SKWD Could Witness a Solid UpsideThere has been increasing optimism among analysts lately about the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher. And that could be a legitimate reason to expect an upside in the stock. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current year, five estimates have moved higher over the last 30 days compared to no negative revision. As a result, the Zacks Consensus Estimate has increased 5.5%.

Moreover, SKWD currently has a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Therefore, while the consensus price target may not be a reliable indicator of how much SKWD could gain, the direction of price movement it implies does appear to be a good guide.

After reaching an important support level, Business First Bancshares, Inc. (BFST - Free Report) could be a good stock pick from a technical perspective. BFST recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

Considered an important signifier for a bullish breakout, a golden cross is a technical chart pattern that's formed when a stock's short-term moving average breaks above a longer-term moving average; the most common crossover involves the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.

A successful golden cross event has three stages. It first begins when a stock's price on the decline bottoms out. Then, its shorter moving average crosses above its longer moving average, triggering a positive trend reversal. The third and final phase occurs when the stock maintains its upward momentum.

A golden cross contrasts with a death cross, another widely-followed chart pattern that suggests bearish momentum could be on the horizon.

Over the past four weeks, BFST has gained 6.1%. The company currently sits at a #3 (Hold) on the Zacks Rank, also indicating that the stock could be poised for a breakout.

The bullish case only gets stronger once investors take into account BFST's positive earnings outlook for the current quarter. There have been 3 upward revisions compared to none lower over the past 60 days, and the Zacks Consensus Estimate has moved up as well.

With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on BFST for more gains in the near future.

Telecom Argentina Stet - France Telecom S.A. (TEO - Free Report) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TEO's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross."

A golden cross is a technical chart pattern that can signify a potential bullish breakout. It's formed from a crossover involving a security's short-term moving average breaking above a longer-term moving average, with the most common moving averages being the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.

There are three stages to a golden cross. First, there must be a downtrend in a stock's price that eventually bottoms out. Then, the stock's shorter moving average crosses over its longer moving average, triggering a positive trend reversal. The third stage is when a stock continues the upward momentum to higher prices.

A golden cross is the opposite of a death cross, another technical event that indicates bearish price movement may be on the horizon.

Shares of TEO have been moving higher over the past four weeks, up 12.2%. Plus, the company is currently a #3 (Hold) on the Zacks Rank, suggesting that TEO could be poised for a breakout.

Looking at TEO's earnings expectations, investors will be even more convinced of the bullish uptrend. For the current quarter, there have been 1 change higher compared to none lower over the past 60 days, and the Zacks Consensus Estimate has moved up as well.

With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on TEO for more gains in the near future.

AOS rides strong North American heater demand and strategic acquisitions, though China weakness and rising costs pose challenges.

PALO ALTO, Calif.--(BUSINESS WIRE)--Pathway, the data company building live AI that thinks in real-time like humans do, today announced that its groundbreaking post-Transformer BDH (Dragon Hatchling) architecture now runs on NVIDIA AI infrastructure and AWS's cloud and AI tech stack, enabling a new class of adaptive and continuously learning AI systems. This initiative enables new capabilities transformers do not deliver. Traditional Transformer-based LLMs have grown the market for AI significa.

CHICAGO, IL / ACCESS Newswire / December 1, 2025 / O2 Sponsor Finance, a division of Old Second National Bank (NASDAQ:OSBC), has had a very busy second-half of 2025 with significant new financing activity. O2 Sponsor Finance announced today that it served as Administrative Agent and Co-Lead Arranger of senior secured credit facilities to support Paceline Equity Partners, LLC and Serata Capital Partners, LLC in their acquisition of EventLink Group ("EventLink").

December 01, 2025 11:00 AM EST | Source: APG
Portland, Oregon--(Newsfile Corp. - December 1, 2025) - NAEGELI Deposition & Trial, a nationwide leader in court reporting and litigation support services, continues to demonstrate its commitment to advanced legal technology and client data protection through a high-profile partnership with cybersecurity firm Rubrik. As part of this collaboration, NAEGELI was invited to speak at Rubrik's renowned virtual tech event, Forward 2025, and was recently featured in an in-depth case study published on Rubrik's official website.

At the center of both the conference presentation and case study is Juliette Kivo, Chief Administration Officer of NAEGELI Deposition & Trial. On June 4, Kivo addressed the Forward audience in a keynote-style discussion on how the firm leverages Rubrik's cybersecurity solutions to secure sensitive legal data and streamline operational efficiency. The session offered rare insights into how a legacy legal services provider is future-proofing its infrastructure while upholding the gold standard in confidentiality and compliance.

"At the end of the day, it's about trust." Kivo shared during her talk. "Our clients rely on us to safeguard their most sensitive information during critical moments in their lives. With Rubrik, we are able to uphold and protect that trust every day."

NAEGELI's use of Rubrik spans across platforms integral to the firm's day-to-day communication and collaboration. Rubrik ensures that all files, whether they are deposition transcripts, sealed court exhibits, or internal project communications, are backed up securely and are immediately restorable in the event of accidental deletion or cyber intrusion.

"It is a huge relief knowing that if something is accidentally deleted, we can get it back right away," Kivo added. "Moreover, knowing that our backups cannot be tampered with or deleted, even if a bad actor gained access to our admin credentials, provides us with true peace of mind."

According to the newly published Rubrik case study, the collaboration has helped NAEGELI overcome several pain points common in the legal sector, from communication breakdowns to concerns around long-term file retention. As litigation timelines can span months or even years, maintaining reliable and secure access to historical case files is paramount. With Rubrik, NAEGELI can confidently store and retrieve vital data indefinitely.

"Data protection is not just a best practice," Kivo emphasized. "It's a fundamental responsibility. We need the best tools possible that ensure information is secure, accessible, and preserved for the long haul."

In a profession where the stakes are high and every detail matters, NAEGELI's strategic adoption of Rubrik underscores its larger mission: empowering attorneys and law firms to move cases forward without compromise. Whether it is safeguarding a video deposition, ensuring accurate scheduling through Teams, or protecting sensitive communications, Rubrik's solutions have become an integral part of NAEGELI's operational backbone.

"Cybersecurity is like locking your house at night," Kivo explained. "Of course you hope you will never be targeted, but if you leave your doors and windows wide open, the risk of a break-in rises. Just as you secure your home to keep intruders out, you need to protect your digital assets from cyberthreats."

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275887

The market expects Phreesia (PHR - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended October 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on December 8, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis developer of health care software is expected to post quarterly earnings of $0.00 per share in its upcoming report, which represents a year-over-year change of +100%.

Revenues are expected to be $120.13 million, up 12.5% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 50% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Phreesia?For Phreesia, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1,100.00%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination indicates that Phreesia will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Phreesia would post a loss of$0.07 per share when it actually produced earnings of $0.01, delivering a surprise of +114.29%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Phreesia appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Beneficient (BENF) Shareholder/Analyst Call December 1, 2025 10:00 AM EST

Company Participants

James Silk - Interim Chief Executive Officer

Conference Call Participants

Leicia Savinetti

Presentation

Operator

Hello, and welcome to the Special Meeting of Stockholders of Beneficient. It is my pleasure to introduce James G. Silk the Interim Chief Executive Officer of Beneficient. Mr. Silk, the floor is yours.

James Silk
Interim Chief Executive Officer

Good morning, ladies and gentlemen. I'm James Silk Beneficient's Interim Chief Executive Officer. I will act as Chairman of this meeting, and David Ross, our General Counsel, will act as Secretary of the meeting. Special Meeting of Beneficient is hereby call to order. I would like to welcome our stockholders and guests who are in attendance today.

Additionally, I would like to introduce Leicia Savinetti a representative of Continental Stock Transfer & Trust Company, the company's transfer agent, who will act as our inspector of election. Our transfer agent has been instructed to receive, examine and tabulate the proxies and to report on the voting by proxies.

Copies of the agenda and rules of conduct for this meeting are available in the meeting documents tab located at the top of your screen in the virtual meeting viewing platform. I have in my possession an affidavit sworn to by Continental Stock Transfer & Trust Company and duly signed as to the mailing of the notice of the meeting, which states that on December 7, 2025 the notice of the meeting, together with the related proxy materials was mailed to all stockholders of record as of the close of business on October 27, 2025, the record date for the meeting.

As set forth in the Notice of Special Meeting of Stockholders and the agenda available in the meeting documents tab, the principal items of business for

Recommended For You

Synopsys Inc (NASDAQ:SNPS) stock is on the rise, last seen up 4.6% to trade at $437.27, after reports that Nvidia (NVDA) has invested $2 billion in the electronic design automation name as part of a new partnership.

"The Big Short" investor Michael Burry took aim at electric automaker Tesla in a blog post, saying the Elon Musk-led company is "ridiculously overvalued", days after he voiced concerns about the current AI boom.

December 01, 2025 11:08 ET

 | Source:

MingZhu Logistics Holdings Limited

SHENZHEN, China, Dec. 01, 2025 (GLOBE NEWSWIRE) -- MingZhu Logistics Holdings Limited (Nasdaq: YGMZ, "MingZhu" or the "Company"), today announced that its subsidiary, MingZhu Technology Limited, has officially launched a comprehensive AI upgrade for its robot dog product line. The upgrade introduces an advanced intelligent companion tailored for family and educational use, marking revolutionary improvements over the previous version in interactive intelligence, functional diversity, and safety design.

Features of the Previous Version
The earlier robot dog model primarily supported basic voice command interactions and included 15 remote control functions. Its fixed voice commands and pre-installed music limited user engagement in interaction and creative expression, and it did not support internet connectivity or multi-user recognition, restricting its potential for deeper engagement.

Key Highlights of the Upgraded Version
1. Advanced AI Dialogue System
The upgraded robot dog supports natural, free-flowing conversations, capable of identifying and distinguishing between multiple family members. It features integrated functions such as phone calling, co-creating stories, and English dialogue, and it can recognize various Chinese dialects. It even supports role-playing script games, offering a richer and more immersive interactive experience.

2. Intelligent Educational and Entertainment Applications
With 21 remote control functions and a content creation system that supports user-driven innovation, the robot dog serves as both an educational and entertainment tool. It offers adjustable volume and an extended battery life of up to 8 hours, ensuring reliable use across various scenarios.

3. Safe and Stable Performance
Addressing common issues found in ordinary AI toys, such as fiber shedding, delayed response, unclear voice recognition, overheating, and lagging, this upgraded version delivers clear audio output, stable system operation, and an enhanced memory function that continuously learns and adapts to user habits and preferences.

This upgraded robot dog is now officially available through authorized distribution channels. With its enhanced AI interactivity, versatile functionality, and reliable performance, the product aims to set a new standard in the smart companion robotics industry, offering users a more intelligent, engaging, and seamless experience across home and educational environments.

About MingZhu Logistics Holdings Limited (Nasdaq: YGMZ)

Established in 2002 and headquartered in Shenzhen, China, MingZhu Logistics Holdings Limited is a 4A-rated professional trucking service provider. Based on the Company’s regional logistics terminals in Guangdong Province, MingZhu Logistics Holdings offers tailored solutions to our clients to deliver their goods through our network density and broad geographic coverage across the country by a combination of self-owned fleets tractors and trailers and subcontractors’ fleets. For more information, please visit https://ir.szygmz.com/.

Forward-Looking Statements

The statements in this press release regarding the Company's future expectations, plans and prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding plans, goals, objectives, strategies, future events, expected performance, assumptions and any other statements of fact that have not occurred. Any statements that contain the words “may”, “will”, “want”, “should”, “believe”, “expect”, “anticipate”, “estimate”, “calculate” or similar statements that are not factual in nature are to be considered forward-looking statements. Actual results may differ materially from historical results or from those expressed in these forward-looking statements as a result of a variety of factors. These factors include, but are not limited to, the Company's strategic objectives, the Company's future plans, market demand and user acceptance of the Company's products or services, technological advances, economic trends, the growth of the trucking services market in China, the Company's reputation and brand, the impact of industry competition and bidding, relevant policies and regulations, fluctuations in China's macroeconomic conditions, and the risks and assumptions disclosed in the Company's reports provided to the CSRC (China Security Regulatory Commission). For these and other related reasons, we advise investors not to place any reliance on these forward-looking statements, and we urge investors to review the Company's relevant SEC filings for additional factors that may affect the Company's future results of operations. The Company undertakes no obligation to publicly revise these forward-looking statements subsequent to the filing of these documents as a result of changes in particular events or circumstances.

For further information, please contact.
MingZhu Logistics Holdings Limited:
Junfei Yang
Email: [email protected]
Phone: +86 131-2892-8512

Hologic (HOLX - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Over the past month, shares of this medical device maker have returned +1.4%, compared to the Zacks S&P 500 composite's -0.5% change. During this period, the Zacks Medical - Instruments industry, which Hologic falls in, has gained 6.8%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Hologic is expected to post earnings of $1.09 per share for the current quarter, representing a year-over-year change of +5.8%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.4%.

For the current fiscal year, the consensus earnings estimate of $4.5 points to a change of +5.6% from the prior year. Over the last 30 days, this estimate has changed +0.6%.

For the next fiscal year, the consensus earnings estimate of $4.96 indicates a change of +10.2% from what Hologic is expected to report a year ago. Over the past month, the estimate has changed +1.6%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Hologic is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For Hologic, the consensus sales estimate for the current quarter of $1.07 billion indicates a year-over-year change of +5%. For the current and next fiscal years, $4.28 billion and $4.51 billion estimates indicate +4.4% and +5.4% changes, respectively.

Last Reported Results and Surprise HistoryHologic reported revenues of $1.05 billion in the last reported quarter, representing a year-over-year change of +6.2%. EPS of $1.13 for the same period compares with $1.01 a year ago.

Compared to the Zacks Consensus Estimate of $1.03 billion, the reported revenues represent a surprise of +1.49%. The EPS surprise was +2.73%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Hologic is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Hologic. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Deckers (DECK - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Over the past month, shares of this maker of Ugg footwear have returned +8%, compared to the Zacks S&P 500 composite's -0.5% change. During this period, the Zacks Retail - Apparel and Shoes industry, which Deckers falls in, has gained 4.4%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Deckers is expected to post earnings of $2.76 per share for the current quarter, representing a year-over-year change of -8%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.7%.

For the current fiscal year, the consensus earnings estimate of $6.41 points to a change of +1.3% from the prior year. Over the last 30 days, this estimate has changed +0.2%.

For the next fiscal year, the consensus earnings estimate of $6.8 indicates a change of +6.1% from what Deckers is expected to report a year ago. Over the past month, the estimate has remained unchanged.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Deckers.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For Deckers, the consensus sales estimate for the current quarter of $1.87 billion indicates a year-over-year change of +2.3%. For the current and next fiscal years, $5.36 billion and $5.74 billion estimates indicate +7.6% and +7.1% changes, respectively.

Last Reported Results and Surprise HistoryDeckers reported revenues of $1.43 billion in the last reported quarter, representing a year-over-year change of +9.1%. EPS of $1.82 for the same period compares with $1.59 a year ago.

Compared to the Zacks Consensus Estimate of $1.41 billion, the reported revenues represent a surprise of +1.2%. The EPS surprise was +15.19%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Deckers is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Deckers. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Palantir Technologies Inc. (PLTR - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Shares of this company have returned -16% over the past month versus the Zacks S&P 500 composite's -0.5% change. The Zacks Internet - Software industry, to which Palantir Technologies belongs, has lost 11.9% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Palantir Technologies is expected to post earnings of $0.23 per share for the current quarter, representing a year-over-year change of +64.3%. Over the last 30 days, the Zacks Consensus Estimate has changed +27.5%.

For the current fiscal year, the consensus earnings estimate of $0.73 points to a change of +78.1% from the prior year. Over the last 30 days, this estimate has changed +15.1%.

For the next fiscal year, the consensus earnings estimate of $1.04 indicates a change of +43% from what Palantir Technologies is expected to report a year ago. Over the past month, the estimate has changed +20.5%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Palantir Technologies.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For Palantir Technologies, the consensus sales estimate for the current quarter of $1.35 billion indicates a year-over-year change of +62.8%. For the current and next fiscal years, $4.42 billion and $6.23 billion estimates indicate +54.1% and +41.1% changes, respectively.

Last Reported Results and Surprise HistoryPalantir Technologies reported revenues of $1.18 billion in the last reported quarter, representing a year-over-year change of +62.8%. EPS of $0.21 for the same period compares with $0.1 a year ago.

Compared to the Zacks Consensus Estimate of $1.09 billion, the reported revenues represent a surprise of +8.06%. The EPS surprise was +23.53%.

Over the last four quarters, Palantir Technologies surpassed consensus EPS estimates three times. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Palantir Technologies is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Palantir Technologies. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.

Intuitive Surgical, Inc. (ISRG - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Shares of this company have returned +7.3% over the past month versus the Zacks S&P 500 composite's -0.5% change. The Zacks Medical - Instruments industry, to which Intuitive Surgical belongs, has gained 6.8% over this period. Now the key question is: Where could the stock be headed in the near term?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Intuitive Surgical is expected to post earnings of $2.25 per share, indicating a change of +1.8% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $8.61 points to a change of +17.3% from the prior year. Over the last 30 days, this estimate has remained unchanged.

For the next fiscal year, the consensus earnings estimate of $9.55 indicates a change of +10.9% from what Intuitive Surgical is expected to report a year ago. Over the past month, the estimate has remained unchanged.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for Intuitive Surgical.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

For Intuitive Surgical, the consensus sales estimate for the current quarter of $2.72 billion indicates a year-over-year change of +12.6%. For the current and next fiscal years, $9.92 billion and $11.35 billion estimates indicate +18.7% and +14.5% changes, respectively.

Last Reported Results and Surprise HistoryIntuitive Surgical reported revenues of $2.51 billion in the last reported quarter, representing a year-over-year change of +22.9%. EPS of $2.4 for the same period compares with $1.84 a year ago.

Compared to the Zacks Consensus Estimate of $2.41 billion, the reported revenues represent a surprise of +3.92%. The EPS surprise was +20.6%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Intuitive Surgical is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Intuitive Surgical. However, its Zacks Rank #1 does suggest that it may outperform the broader market in the near term.

Organon (OGN - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Over the past month, shares of this pharmaceutical company have returned +14.2%, compared to the Zacks S&P 500 composite's -0.5% change. During this period, the Zacks Medical Services industry, which Organon falls in, has gained 5.2%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Organon is expected to post earnings of $0.74 per share for the current quarter, representing a year-over-year change of -17.8%. Over the last 30 days, the Zacks Consensus Estimate has changed -22.5%.

The consensus earnings estimate of $3.78 for the current fiscal year indicates a year-over-year change of -8%. This estimate has changed -1.4% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $3.93 indicates a change of +3.9% from what Organon is expected to report a year ago. Over the past month, the estimate has changed -2.5%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Organon.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Organon, the consensus sales estimate of $1.53 billion for the current quarter points to a year-over-year change of -3.8%. The $6.24 billion and $6.09 billion estimates for the current and next fiscal years indicate changes of -2.5% and -2.5%, respectively.

Last Reported Results and Surprise HistoryOrganon reported revenues of $1.6 billion in the last reported quarter, representing a year-over-year change of +1.3%. EPS of $1.01 for the same period compares with $0.87 a year ago.

Compared to the Zacks Consensus Estimate of $1.57 billion, the reported revenues represent a surprise of +2.02%. The EPS surprise was +8.6%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Organon is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Organon. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

MIAMI, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Standard Premium Finance Holdings, Inc. (OTCQX: SPFX) (“Standard Premium”), a leading specialty finance company, announces new state licensing approvals that expand its operating footprint to 40 states. In 2025, Standard Premium received approvals in New Jersey, New York, North Dakota, Pennsylvania and Utah. These states join the company’s 2024 expansion into Connecticut, Michigan, Rhode Island, Montana, New Mexico and Oregon, further solidifying Standard Premium’s position as one of the most widely licensed premium finance companies.

“This milestone underscores our continued commitment to responsible growth and to serving agents, carriers and insureds across the country,” says William Koppelmann, CEO, Standard Premium. “Our recently expanded $115 million line of credit more than doubled our availability of capital. Now is the time to execute on our geographic growth plan.”

The continued expansion reflects Standard Premium’s disciplined approach to market entry and regulatory compliance. By maintaining strong relationships with state departments of insurance and investing in operational readiness, the company ensures a seamless onboarding process for agents and policyholders.

“Achieving 40 state approvals marks an important step in our long-term growth strategy. Expanding our geographic reach not only broadens our customer base but also strengthens our portfolio diversification,” adds Brian Krogol, CFO, Standard Premium.

These licensing achievements support the company’s broader initiatives to expand into new regional markets and deliver consistent value to stakeholders. In 2025 Standard Premium has been featured in trade media including Insurance Thought Leadership, AM Best and CityBiz.

About Standard Premium Finance Holdings, Inc. 

Standard Premium Finance Holdings, Inc. (OTCQX: SPFX), is a specialty finance company which has financed premiums on over $2 Billion of property and casualty insurance policies since 1991. We currently operate in 38 states and are seeking M&A opportunities of synergistic businesses to leverage economies of scale. https://www.standardpremium.com/ 

Cautionary Statement Regarding Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27a of the Securities Act of 1933, as amended, and Section 21e of the Securities Exchange Act of 1934, as amended with regard to our anticipated future growth and outlook. Our actual results may differ from expectations presented or implied herein and, consequently, you should not rely on these forward-looking statements as predictions of future events. We do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in our expectations or any change in events, conditions or results.

Additional information concerning risk factors relating to our business is contained in Item 1A Risk Factors of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 10, 2025 which is available on the SEC’s website at www.sec.gov or on the Investor Relations section of our website, standardpremium.com.

Media:
Nicholas Turchiano
CPR Marketing
[email protected]  
201-641-1911x35

Key Takeaways Petrobras cut its 2026-2030 investment plan by 2% to $109B amid lower oil price assumptions.Most spending backs ongoing projects, with $69.2B directed to exploration and production.Petrobras targets 2.7 mbbl/d by 2028 and plans eight new production systems by 2030.
Petrobras (PBR - Free Report) , Brazil’s state-controlled integrated oil and gas company, has officially outlined its investment strategy for the next five years, with a comprehensive business plan aimed at navigating the challenges of fluctuating oil prices and global market shifts. The 2026-2030 Business Plan marks a critical phase in the company’s evolution, as it adjusts financial strategies to align with a revised, lower estimate for international oil prices.

Petrobras Investment Overview: A 2% Reduction in BudgetIn a significant development, Petrobras’ board of directors announced a 2% reduction in total investment budget for the 2026-2030 period, setting it at $109 billion. This decision reflects the company's adaptation to a less favorable oil price environment, driven by market volatility and global economic factors. This marks the first time since the inauguration of president Luiz Inácio Lula da Silva in 2023 that Petrobras has revised its five-year spending plan downward.

Of the total $109 billion, the vast majority, approximately $91 billion, will be allocated to ongoing projects that are already in the implementation phase. These include major investments that are essential for maintaining Petrobras' position as a leading energy provider in Brazil and globally. Additionally, $10 billion has been earmarked for projects that are pending final budget approvals and require further financing analysis.

Exploration and Production Investments: The Focus on Pre-Salt FieldsA significant portion of the Business Plan for 2026-2030 is dedicated to expanding Petrobras’ exploration and production capabilities, with $69.2 billion set aside for these critical activities. The company has outlined its commitment to increasing production from Brazil’s world-renowned pre-salt fields, which will receive 62% of the total exploration and production investment. This allocation highlights the strategic importance of pre-salt reserves in Petrobras’ long-term growth and stability.

In addition to pre-salt developments, 24% of the exploration and production (“E&P”) budget is dedicated to post-salt fields, while 10% will go toward exploration activities aimed at expanding Petrobras’ reserves. The remaining funds will be directed toward enhancing onshore projects, shallow-water assets, international ventures and initiatives focused on decarbonization and technology advancement.

Petrobras’ Production Targets and OutlookPetrobras' production goals for the next decade are ambitious. The company expects peak oil production to reach an impressive 2.7 million barrels per day (mbbl/d) by 2028, a significant milestone that will set its role as a major energy supplier in both the Latin American and global markets. By 2028 and 2029, total production is projected to hit 3.4 million barrels of oil equivalent (mboe) per day, including both oil and gas, reinforcing the company’s diversified energy output.

In the near term, Petrobras has raised its short-term oil production target to 2.5 mbbl/d for the coming year, up from the previously projected 2.4 mbbl/d. This adjustment reflects the company’s continued ability to adapt to changing market dynamics while maintaining a steady growth trajectory in oil production.

New Projects and Technological Advancements: Leading the Energy TransitionPetrobras is committed to innovation and sustainability, as evidenced by its planned implementation of eight new production systems by 2030. These systems will support Petrobras’ ability to meet its ambitious production targets and ensure the long-term sustainability of operations. Furthermore, the company has outlined plans for an additional 10 projects post-2030, which signals an ongoing commitment to expanding its capabilities well into the future.

One key focus of Petrobras’ future strategy is the Equatorial Margin, a region that holds significant promise for new oil discoveries. Petrobras has already received permits to drill its first well in this region, with plans to drill a total of 15 wells in the coming years.

Given the expectation of continued weak crude oil prices in the coming years, Petrobras may reassess some of the 15 wells it plans to drill in the Equatorial Margin, as mentioned by CEO Magda Chambriard in Reuters. The Equatorial Margin represents an exciting frontier for the company, which will continue to prioritize drilling activities based on the price of Brent crude oil and the overall market conditions.

Dividends and Financial Management: Ensuring Shareholder ReturnsPetrobras’ commitment to shareholder returns remains a central aspect of its long-term strategy. The company has pledged to maintain regular dividend payouts in the range of $45-$50 billion over the 2026-2030 period. This commitment will provide investors with a steady stream of income, reinforcing Petrobras’ position as a reliable dividend payer.

In addition to the dividend strategy, Petrobras has also set a firm limit on its gross debt, maintaining a cap of $75 billion. This conservative approach to debt management ensures that the company remains financially robust, even as it navigates the complex and often unpredictable landscape of the global energy sector.

Impact of Global Oil Price FluctuationsThe reduction in Petrobras’ investment budget can largely be attributed to the unpredictable nature of global oil prices, which have fluctuated significantly in recent years. Petrobras, as a major player in the oil industry, is sensitive to these price changes, and the ability to adjust the spending plan accordingly is a testament to its resilience.

Despite the 2% reduction in the overall investment budget, Petrobras remains confident in its ability to execute its long-term strategic vision. The company’s focus on pre-salt reserves, alongside the commitment to new production systems and exploration projects, positions it well to continue contributing to Brazil's energy security and economic growth.

Decarbonization and Sustainability InitiativesIn line with global energy trends, Petrobras is also investing in decarbonization projects aimed at reducing the environmental impact of its operations. A portion of the allocated budget will be directed toward green technology, carbon capture initiatives and sustainability programs. This aligns with the broader energy transition goals set by Brazil and the global community, which are increasingly focused on reducing carbon emissions and advancing cleaner energy alternatives.

Conclusion: Petrobras’ Strategic Path ForwardPetrobras’ Business Plan 2026-2030 reflects a balanced approach to growth, innovation and financial responsibility. By focusing on high-value exploration and production projects, alongside a commitment to sustainability and technological advancements, the company is positioning itself for continued success in an ever-evolving energy landscape. Its ability to adapt to lower oil prices while maintaining ambitious production goals and shareholder returns demonstrates Petrobras’ resilience and forward-thinking leadership in the global energy sector.

As Petrobras moves forward, it remains a key player in Brazil's energy future, contributing significantly to both national economic stability and the global energy mix. The strategic investment plan will undoubtedly shape the company's trajectory for the next decade, ensuring that it remains at the forefront of the oil and gas industry.

PBR's Zacks Rank & Key PicksCurrently, PBR has a Zacks Rank #3 (Hold).

Investors interested in the energy sector might look at some better-ranked stocks like USA Compression Partners (USAC - Free Report) , Oceaneering International (OII - Free Report) and Canadian Natural Resources Limited (CNQ - Free Report) , which sport a Zacks Rank #1 (Strong Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

USA Compression Partners is valued at $3.01 billion. The company is a leading provider of natural gas compression services in the United States. USA Compression Partners specializes in the design, operation and maintenance of compression equipment for the energy sector, focusing on helping customers optimize their natural gas infrastructure.

Oceaneering International is valued at $2.43 billion. The company is a global provider of engineered services and products to the offshore energy, aerospace and defense industries. Oceaneering International specializes in underwater robotics, remotely operated vehicles and subsea engineering solutions for offshore oil and gas exploration and production.

Canadian Natural Resources is valued at $70.35 billion. The company is one of Canada's largest independent oil and gas exploration and production companies. With a diverse portfolio of assets spanning oil sands, conventional oil, and natural gas, Canadian Natural Resources is focused on sustainable energy development and long-term growth.